The use of botulinum toxin in ophthalmology
DOI:
https://doi.org/10.56782/pps.253Keywords:
botulinum toxin, ophthalmology, strabismus, tearing, eyelid spasmAbstract
Botulinum toxin is an exotoxin produced by the anaerobic bacteria Clostridium botulinum. It is one of the most potent neurotoxins known and used in medicine. Its versatile use covers various fields of medicine, including ophthalmology. Botulinum toxin is widely used in ophthalmology for both therapeutic and aesthetic purposes. Thanks to its mechanism of action of inhibiting the release of acetylcholine, it leads to muscle paresis and inhibition of the function of the exocrine glands. This makes it effective in treating such conditions as, for example, strabismus, nystagmus, epiphora, and eyelid spasm. On the other hand, in aesthetic medicine it is used to reduce "crow's feet". The properties of botulinum toxin make it a beneficial therapeutic tool used in ophthalmology. Studies show its effectiveness in treating various ocular muscle dysfunctions and excessive tearing. The purpose of this article is to discuss the current indications and potential uses of botulinum toxin in ophthalmology.
Downloads
References
1. Sobel, J. Botulism. Clin. Infect. Dis. 2005, 41, 1167-1173. DOI: 10.1086/444507 DOI: https://doi.org/10.1086/444507
2. Wan, M.J.; AlShaker, S.; Hunter, D G. Use of Botulinum Toxin in Ophthalmology. Handb. Exp. Pharmacol. 2021, 263, 147-160. DOI: 10.1007/164_2019_325 DOI: https://doi.org/10.1007/164_2019_325
3. Dressler, D.; Adib Saberi, F. Botulinum Toxin: Mechanisms of Action. Eur. Neurol. 2005, 53, 3–9. DOI: 10.1159/000083259 DOI: https://doi.org/10.1159/000083259
4. Nigam, P. K.; Nigam, A. Botulinum toxin. Indian J. Dermatol. 2010, 55, pp. 8–14. DOI: 10.4103/0019-5154.60343 DOI: https://doi.org/10.4103/0019-5154.60343
5. Dutta, S.R.; Passi, D.; Singh, M.; Singh, P.; Sharma, S.; Sharma, A. Botulinum toxin the poison that heals: A brief review. Natl. J. Maxillofac. Surg. 2016, 7, 10–16. DOI: 10.4103/0975-5950.196133 DOI: https://doi.org/10.4103/0975-5950.196133
6. Lam, K.H.; Jin, R. Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery. Curr. Opin. Struct. Biol. 2015, 31, 89–95. DOI: 10.1016/j.sbi.2015.03.013 DOI: https://doi.org/10.1016/j.sbi.2015.03.013
7. Montal, M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 2010, 79, 591-617. DOI: 10.1146/annurev.biochem.051908.125345 DOI: https://doi.org/10.1146/annurev.biochem.051908.125345
8. Breidenbach, M.A.; Brunger, A.T. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature. 2004, 432, 925-929. DOI: 10.1038/nature03123 DOI: https://doi.org/10.1038/nature03123
9. Dressler, D.; Saberi, F.A.; Barbosa, E.R. Botulinum toxin: mechanisms of action. Arq. Neuropsiquiatri. 2005, 63, 180-185. DOI: 10.1590/s0004-282x2005000100035 DOI: https://doi.org/10.1590/S0004-282X2005000100035
10. Dutton, J.J.; Fowler, A.M. Botulinum toxin in ophthalmology. Surv. Ophthalmol. 2007, 52, 13-31. DOI: 10.1016/j.survophthal.2006.10.003 DOI: https://doi.org/10.1016/j.survophthal.2006.10.003
11. Gregory, S.; Acharya, K.R. A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins (Basel). 2023, 15, Art. No: 92. DOI: 10.3390/toxins15020092 DOI: https://doi.org/10.3390/toxins15020092
12. Montecucco, C.; Molgó, J. Botulinum neurotoxins: revival of an old killer. Curr. Opin. Pharmacol. 2005, 5, 274-279. DOI: 10.1016/j.coph.2004.12.006 DOI: https://doi.org/10.1016/j.coph.2004.12.006
13. Simpson, L. L. Identification of the major steps in botulinum toxin action. Ann. Rev. Pharmacol. Toxicol. 2004, 44, 167-193. DOI: 10.1146/annurev.pharmtox.44.101802.121554 DOI: https://doi.org/10.1146/annurev.pharmtox.44.101802.121554
14. Leszczynska, A.; Nowicka, D.; Pillunat, L.E.; Szepietowski, J.C. Five decades of the use of botulinum toxin in ophthalmology. Indian J. Ophthalmol. 2024, 72, 789-795. DOI: 10.4103/IJO.IJO_1030_23 DOI: https://doi.org/10.4103/IJO.IJO_1030_23
15. Binenbaum, G.; Chang, M.Y.; Heidary, G.; Morrison, D.G.; Trivedi, R.H.; Galvin, J.A.; Pineles, S.L. Botulinum Toxin Injection for the Treatment of Strabismus: A Report by the American Academy of Ophtalmology. Ophtalmology 2021, 128, 1766-1776 DOI: 10.1016/j.ophtha.2021.05.009 DOI: https://doi.org/10.1016/j.ophtha.2021.05.009
16. Bort-Martí, A.R.; Rowe, F.J.; Ruiz Sifre, L.; et al. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst. Rev. 2023, 3, Art. No: CD006499. DOI: 10.1002/14651858.CD006499.pub5 DOI: https://doi.org/10.1002/14651858.CD006499.pub5
17. Medicine after the diploma. Available online: https://podyplomie.pl/okulistyka/38666,ortoptyka-zastosowanie-toksyny-botulinowej-i-bupiwakainy-w-leczeniu-roznych-typow-zeza?page=4&srsltid=AfmBOoru2GCUBOa_CRUVfqVqCHgmhl-vByJx4T8btQkVyFWN9TyGLf8j (accessed 07.07.2024)
18. Sabetti, L.; Guetti, F.; Pomanti, V.; Murano, G. Botulinum Toxin for the Treatment of Nystagmus Associated with Exotropia. Open J. Ophthalmol. 2022, 12, Art. No: 4. DOI: 10.4236/ojoph.2022.124036 DOI: https://doi.org/10.4236/ojoph.2022.124036
19. Venturi, N.; Adams, G.; Theodorou, M. The Use of Botulinum Toxin in a Case of Acquired Periodic Alternating Nystagmus. Br. Ir. Orthopt. J. 2021, 17, 85-90. DOI: 10.22599/bioj.170 DOI: https://doi.org/10.22599/bioj.170
20. Başar, E.; Arıcı, C. Use of Botulinum Neurotoxin in Ophthalmology. Turk. J. Ophthalmol. 2016, 46, 282–290. DOI: 10.4274/tjo.57701 DOI: https://doi.org/10.4274/tjo.57701
21. Schinwelski, M. Blepharospasm – from diagnosis to proper treatment. OphthaTherapy. 2019, 6(1), 43-50. DOI: 10.24292/01.OT.300319.07 DOI: https://doi.org/10.24292/01.OT.300319.07
22. Hellman, A.; Torres-Russotto, D. Botulinum toxin in the management of blepharospasm: current evidence and recent developments. Ther. Adv. Neurol. Disord. 2015, 8, 82–91. DOI: 10.1177/1756285614557475 DOI: https://doi.org/10.1177/1756285614557475
23. Scott, A.B.; Fahn, S.; Brin, M.F. Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023, 102, Art. No: e32374. DOI: 10.1097/MD.0000000000032374 DOI: https://doi.org/10.1097/MD.0000000000032374
24. Dressler, D.; Pan, L.; Saberi, F.A. Antibody-induced failure of botulinum toxin therapy: re-start with low-antigenicity drugs offers a new treatment opportunity. J. Neural. Transm. (Vienna). 2018, 125, 1481-1486. DOI: 10.1007/s00702-018-1911-3 DOI: https://doi.org/10.1007/s00702-018-1911-3
25. Alsuhaibani, A.H.; Eid, S.A. Botulinum toxin injection and tear production. Curr. Opin. Ophthalmol. 2018, 29, 428-433. DOI: 10.1097/ICU.0000000000000506 DOI: https://doi.org/10.1097/ICU.0000000000000506
26. Pattanayak, S.; Sharma, P.K.; Samikhya, S.; et al. Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome. Indian J. Ophthalmol. 2022, 70, 1339-1342. DOI: 10.4103/ijo.IJO_2909_21 DOI: https://doi.org/10.4103/ijo.IJO_2909_21
27. Lima-Fontes, M.; Leuzinger-Dias, M.; Falcão-Reis, F.; Sousa, C. Injection of Botulinum Toxin A in the Lacrimal Gland for Treatment of Epiphora in Crocodile Tears Syndrome – A Case Report. Int. Med. Case Rep. J. 2022, 15, 537–542. DOI: 10.2147/IMCRJ.S379024 DOI: https://doi.org/10.2147/IMCRJ.S379024
28. Deka, A.; Saikia, S.P. Lower lid entropion correction with botulinum toxin injection. Oman J. Ophthalmol. 2010, 3, 158–159. DOI: 10.4103/0974-620X.71909 DOI: https://doi.org/10.4103/0974-620X.71909
29. Steel, D.H.; Hoh, H.B.; Harrad, R.A.; Collins, C.R. Botulinum toxin for the temporary treatment of involutional lower lid entropion: a clinical and morphological study. Eye (Lond). 1997, 11, 472-475. DOI: 10.1038/eye.1997.128 DOI: https://doi.org/10.1038/eye.1997.128
30. Carruthers, J.; Stubbs, H.A. Botulinum Toxin for Benign Essential Blepharospasm, Hemifacial Spasm and Age-Related Lower Eyelid Entropion. Can. J. Neurol. Sci. 1987, 14, 42 – 45. DOI: 10.1017/s0317167100026159 DOI: https://doi.org/10.1017/S0317167100026159
31. Rita, M.R.H.; Deepa, M.; Gitanjali, V.C.; Tinu, S.R.; et al. Lagophthalmos: An etiological lookout to frame the decision for management. Indian J. Ophthalmol. 2022, 70, 3077–3082. DOI: 10.4103/ijo.IJO_3017_21 DOI: https://doi.org/10.4103/ijo.IJO_3017_21
32. Medicine after the diploma. Available online: https://podyplomie.pl/okulistyka/33990,mozliwosci-leczenia-niedomykalnosci-szpary-powiekowej-spowodowanej-utrwalonym-porazeniem-nerwu?srsltid=AfmBOoqxhV-w6y9wU2Y3YjEF9pysSSbWF7DQdra8k5dKA0LtRbkWg2Qf (accessed 10.07.2024).
33. Yücel, O.E.; Artürk, N. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis. Ophthalmic Plast. Reconstr. Surg. 2012, 28, 256-260. DOI: 10.1097/IOP.0b013e31824ee702 DOI: https://doi.org/10.1097/IOP.0b013e31824ee702
34. Siastała, P. Methods of revitalization of the eye area with botulinum toxin from the point of view of an ophthalmologist. Aesthet. Cosmetol. 2019, 8(1), 111-115.
35. Naik, M.N.; Soparkar, Ch.Ns.; Murthy, R.; Honavar, S.G. Botulinum Toxin in Ophthalmic Plastic Surgery. Indian J. Ophthalmol. 2005, 53, 279-288. DOI: 10.4103/0301-4738.18915 DOI: https://doi.org/10.4103/0301-4738.18915
36. Carruthers, A.; Carruthers, J.; De Boulle, K. Treatment of crow’s feet lines and forehead lines with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023, 102, Art. No: e32496. DOI: 10.1097/MD.0000000000032496 DOI: https://doi.org/10.1097/MD.0000000000032496
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Katarzyna Łysiak, Anna Łysiak, Barbara Maziarz, Paulina Przywara, Natalia Bogumiłło, Kinga Ściurka, Julia Ignacak, Mikołaj Borek
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
